Increased contextual fear conditioning in inos knockout mice: Additional evidence for the involvement of nitric oxide in stress-related disorders and contribution of the endocannabinoid system

International Journal of Neuropsychopharmacology

Volumn 18, Issue 8, 2015, Pages 1-12

  Lisboa, Sabrina F ^a   Gomes, Felipe V ^a   Silva, Andra L ^a   Uliana, Daniela L ^a   Camargo, Laura H A ^a   Guimars, Francisco S ^a   Cunha, Fernando Q ^a   Joca, Sia R L ^a   Resstel, Leonardo B M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

7 nitroindazole; AM281; anandamide; CB1 receptors; extinction; fear conditioning; nitric oxide; URB597; WIN55,212 2

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 7 NITROINDAZOLE; ANANDAMIDE; CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID RECEPTOR AGONIST; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; ENDOCANNABINOID; FATTY ACID AMIDASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; 7-NITROINDAZOLE; AMIDE; ARACHIDONIC ACID DERIVATIVE; BENZAMIDE DERIVATIVE; BENZOXAZINE DERIVATIVE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CARBAMIC ACID DERIVATIVE; CYCLOHEXYL CARBAMIC ACID 3'-CARBAMOYLBIPHENYL-3-YL ESTER; ENZYME INHIBITOR; INDAZOLE DERIVATIVE; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; NOS2 PROTEIN, MOUSE; PYRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEAR; GENE EXPRESSION; GENE INACTIVATION; HIPPOCAMPUS; MALE; MEDIAL PREFRONTAL CORTEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REINFORCEMENT; SIGNAL TRANSDUCTION; STRESS; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CATALEPSY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; MENTAL STRESS; METABOLISM; PHYSIOLOGY; PREFRONTAL CORTEX;

ANIMALS; ARACHIDONIC ACIDS; BENZAMIDES; BENZOXAZINES; CANNABINOID RECEPTOR AGONISTS; CANNABINOID RECEPTOR ANTAGONISTS; CARBAMATES; CONDITIONING (PSYCHOLOGY); ENDOCANNABINOIDS; ENZYME INHIBITORS; EXTINCTION, PSYCHOLOGICAL; FEAR; FREEZING REACTION, CATALEPTIC; HIPPOCAMPUS; INDAZOLES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHOLINES; NAPHTHALENES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; POLYUNSATURATED ALKAMIDES; PREFRONTAL CORTEX; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; RNA, MESSENGER; STRESS, PSYCHOLOGICAL;

EID: 84931269309     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyv005     Document Type: Article

References (103)

1. Abu-Ghanem Y, Cohen H, Buskila Y, Grauer E, Amitai Y (2008) Enhanced stress reactivity in nitric oxide synthase type 2 mutant mice: findings in support of astrocytic nitrosative modulation of behavior. Neuroscience 156:257-265
2. Aguiar DC, Guimaraes FS (2009) Blockade of NMDA receptors and nitric oxide synthesis in the dorsolateral periaqueductal gray attenuates behavioral and cellular responses of rats exposed to a live predator. J Neurosci Res 87:2418-2429
3. Amitai Y (2010) Physiologic role for "inducible" nitric oxide synthase: a new form of astrocytic-neuronal interface. Glia 58:1775-1781
4. Amstadter AB, Nugent NR, Koenen KC (2009) Genetics of PTSD: Fear conditioning as a model for future research. Psychiatr Ann 39:358-367
5. Battista N, Fezza F, Finazzi-Agro A, Maccarrone M (2006) The endocannabinoid system in neurodegeneration. Ital J Biochem 55:283-289
6. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal biochem 72:248-254
7. Brosnan CF, Lee SC, Liu J (1997) Regulation of inducible nitric oxide synthase expression in human glia: implications for inflammatory central nervous system diseases. Biochem Soc Trans 25:679-683
8. Buskila Y, Abu-Ghanem Y, Levi Y, Moran A, Grauer E, Amitai Y (2007) Enhanced astrocytic nitric oxide production and neuronal modifications in the neocortex of a NOS2 mutant mouse. PloS one 2:e843
9. Camuesco D, Comalada M, Rodriguez-Cabezas ME, Nieto A, Lorente MD, Concha A, Zarzuelo A, Galvez J (2004) The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br J Pharmacol 143:908-918
10. Capuron L, Miller AH (2011) Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 130:226-238
11. Contestabile A (2000) Roles of NMDA receptor activity and nitric oxide production in brain development. Brain Res Brain Res Rev 32:476-509
12. Cuzzocrea S, Zingarelli B, Hake P, Salzman AL, Szabo C (1998) Antiinflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation. Free Radic Biol Med 24:450-459
13. Demas GE, Kriegsfeld LJ, Blackshaw S, Huang P, Gammie SC, Nelson RJ, Snyder SH (1999) Elimination of aggressive behavior in male mice lacking endothelial nitric oxide synthase. J Neurosci 19:RC30
14. De Petrocellis L, Cascio MG, Di Marzo V (2004) The endocannabinoid system: a general view and latest additions. Br J Pharmacol 141:765-774
15. Dere E, De Souza Silva MA, Topic B, Fiorillo C, Li JS, Sadile AG, Frisch C, Huston JP (2002) Aged endothelial nitric oxide synthase knockout mice exhibit higher mortality concomitant with impaired open-field habituation and alterations in forebrain neurotransmitter levels. Genes Brain Behav 1:204-213
16. Di Marzo V, Petrosino S (2007) Endocannabinoids and the regulation of their levels in health and disease. Curr Opin Lipidol 18:129-140
17. Dinerman JL, Dawson TM, Schell MJ, Snowman A, Snyder SH (1994) Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc Natl Acad Sci U S A 91:4214-4218
18. Esplugues JV (2002) NO as a signalling molecule in the nervous system. Br J Pharmacol 135:1079-1095
19. Fabri DR, Hott SC, Reis DG, Biojone C, Correa FM, Resstel LB (2014) The expression of contextual fear conditioning involves activation of a NMDA receptor-nitric oxide-cGMP pathway in the dorsal hippocampus of rats. Eur Neuropsychopharmacol 24:1676-1686
20. Fernandez-Ruiz J, Romero J, Velasco G, Tolon RM, Ramos JA, Guzman M (2007) Cannabinoid CB2 receptor: a new target for controlling neural cell survival? Trends Pharmacol Sci 28:39-45
21. Fernandez-Ruiz J, Pazos MR, Garcia-Arencibia M, Sagredo O, Ramos JA (2008) Role of CB2 receptors in neuroprotective effects of cannabinoids. Mol Cell Endocrinol 286:S91-96
22. Forestiero D, Manfrim CM, Guimaraes FS, de Oliveira RM (2006) Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats. Psychopharmacology (Berl) 184:166-172
23. Frisch C, Dere E, Silva MA, Godecke A, Schrader J, Huston JP (2000) Superior water maze performance and increase in fear-related behavior in the endothelial nitric oxide synthase- deficient mouse together with monoamine changes in cerebellum and ventral striatum. J Neurosci 20:6694-6700
24. Galecki P, Maes M, Florkowski A, Lewinski A, Galecka E, Bienkiewicz M, Szemraj J (2010) An inducible nitric oxide synthase polymorphism is associated with the risk of recurrent depressive disorder. Neurosci Lett 486:184-187
25. Galecki P, Maes M, Florkowski A, Lewinski A, Galecka E, Bienkiewicz M, Szemraj J (2011) Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder. J Affect Disord 129:175-182
26. Garcia-Bueno B, Caso JR, Leza JC (2008) Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms. Neurosci Biobehav Rev 32:1136-1151
27. Gilhotra N, Dhingra D (2009) Involvement of NO-cGMP pathway in anti-Anxiety effect of aminoguanidine in stressed mice. Prog Neuropsychopharmacol Biol Psych 33:1502-1507
28. Gokcek-Sarac C, Karakurt S, Adali O, Jakubowska-Dogru E (2012) Correlation between hippocampal levels of neural, epithelial and inducible NOS and spatial learning skills in rats. Behav Brain Res 235:326-333
29. Gomes FV, Casarotto PC, Resstel LB, Guimaraes FS (2011) Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice. Prog Neuropsychopharmacol Biol Psych 35:434-438
30. Goshen I, Yirmiya R (2009) Interleukin-1 (IL-1): a central regulator of stress responses. Front Neuroendocrinol 30:30-45
31. Guimaraes FS, Beijamini V, Moreira FA, Aguiar DC, de Lucca AC (2005) Role of nitric oxide in brain regions related to defensive reactions. Neurosci Biobehav Rev 29:1313-1322
32. Hampson RE, Miller F, Palchik G, Deadwyler SA (2011) Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity. Neuropharmacology 60:944-952
33. Harvey BH, Oosthuizen F, Brand L, Wegener G, Stein DJ (2004) Stress-restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus. Psychopharmacology (Berl) 175:494-502
34. Heneka MT, Feinstein DL (2001) Expression and function of inducible nitric oxide synthase in neurons. J Neuroimmunol 114:8-18
35. Herencia F, Ferrandiz ML, Ubeda A, Guillen I, Dominguez JN, Charris JE, Lobo GM, Alcaraz MJ (2001) 4-dimethylamino- 3', 4'-dimethoxychalcone downregulates iNOS expression and exerts anti-inflammatory effects. Free Radic Biol Med 30:43-50
36. Holscher C, McGlinchey L, Anwyl R, Rowan MJ (1996) 7-Nitro indazole, a selective neuronal nitric oxide synthase inhibitor in vivo, impairs spatial learning in the rat. Learn Mem 2:267-278
37. Ji H, Tan S, Igarashi J, Li H, Derrick M, Martasek P, Roman LJ, Vasquez-Vivar J, Poulos TL, Silverman RB (2009) Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy. Ann Neurol 65:209-217
38. Joca SR, Guimaraes FS (2006) Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressantlike effects. Psychopharmacology (Berl) 185:298-305
39. Jovanovic T, Norrholm SD, Blanding NQ, Davis M, Duncan E, Bradley B, Ressler KJ (2010) Impaired fear inhibition is a biomarker of PTSD but not depression. Depress Anxiety 27:244-251
40. Kamprath K, Marsicano G, Tang J, Monory K, Bisogno T, Di Marzo V, Lutz B, Wotjak CT (2006) Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. J Neurosci 26:6677-6686
41. Kelley JB, Anderson KL, Itzhak Y (2010) Pharmacological modulators of nitric oxide signaling and contextual fear conditioning in mice. Psychopharmacology (Berl) 210:65-74
42. Kelley JB, Balda MA, Anderson KL, Itzhak Y (2009) Impairments in fear conditioning in mice lacking the nNOS gene. Learn Mem 16:371-378
43. Kim SH, Won SJ, Mao XO, Ledent C, Jin K, Greenberg DA (2006) Role for neuronal nitric-oxide synthase in cannabinoid- induced neurogenesis. J Pharmacol Exp Ther 319:150-154
44. Kirchner L, Weitzdoerfer R, Hoeger H, Url A, Schmidt P, Engelmann M, Villar SR, Fountoulakis M, Lubec G, Lubec B (2004) Impaired cognitive performance in neuronal nitric oxide synthase knockout mice is associated with hippocampal protein derangements. Nitric oxide 11:316-330
45. Lafenetre P, Chaouloff F, Marsicano G (2007) The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction. Pharmacol Res 56:367-381
46. Lawford BR, Morris CP, Swagell CD, Hughes IP, Young RM, Voisey J (2013) NOS1AP is associated with increased severity of PTSD and depression in untreated combat veterans. J Affect Disord 147:87-93
47. Ligresti A, Cascio MG, Di Marzo V (2005) Endocannabinoid metabolic pathways and enzymes. Curr Drug Targets CNS Neurol Disord 4:615-623
48. Lisboa SF, Guimaras FS, Resstel LBM (2011) Anxiety-behavior modulated by ventral medial prefrontal cortex of rats submitted to the vogel conflict test involves a local NMDA receptor and nitric oxide. J Behav Brain Sci 1:181-187
49. Lisboa SF, Guimaraes FS (2012) Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray. Neuropharmacology 62:2455-2462
50. Lisboa SF, Magesto AC, Aguiar JC, Resstel LB, Guimaraes FS (2013) Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats. Neuropharmacology 75C:86-94
51. Lisboa SF, Camargo LH, Magesto AC, Resstel LB, Guimaraes FS (2014) Cannabinoid modulation of predator fear: involvement of the dorsolateral periaqueductal gray. Int J Neuropsychopharmacol 17:1193-1206
52. Maccarrone M, Battista N, Centonze D (2007) The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases. Prog Neurobiol 81:349-379
53. Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R (2011) The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2, 3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psych 35:702-721
54. Maes M, Mihaylova I, Kubera M, Ringel K (2012) Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression. Prog Neuropsychopharmacol Biol Psych 36:169-175
55. Mahan AL, Ressler KJ (2012) Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder. Trends Neurosci 35:24-35
56. Maren S (1998) Effects of 7-nitroindazole, a neuronal nitric oxide synthase (nNOS) inhibitor, on locomotor activity and contextual fear conditioning in rats. Brain Res 804:155-158
57. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgansberger W, Di Marzo V, Lutz B (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418:530-534
58. Mashimo H, Goyal RK (1999) Lessons from genetically engineered animal models. IV. Nitric oxide synthase gene knockout mice. Am J Physiol 277:G745-750
59. Medeiros R, Prediger RD, Passos GF, Pandolfo P, Duarte FS, Franco JL, Dafre AL, Di Giunta G, Figueiredo CP, Takahashi RN, Campos MM, Calixto JB (2007) Connecting TNF-Alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein. J Neurosci 27:5394-5404
60. Miller AH, Haroon E, Raison CL, Felger JC (2013) Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety 30:297-306
61. Minghetti L, Levi G (1998) Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog Neurobiol 54:99-125
62. Moghaddam B (1993) Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J Neurochem 60:1650-1657
63. Monji A, Kato T, Kanba S (2009) Cytokines and schizophrenia: microglia hypothesis of schizophrenia. Psychiatry Clin Neurosci 63:257-265
64. Montezuma K, Biojone C, Lisboa SF, Cunha FQ, Guimaraes FS, Joca SR (2011) Inhibition of iNOS induces antidepressant-like effects in mice: Pharmacological and genetic evidence. Neuropharmacology. Neuropharmacol 62:485-491
65. Moraes-Neto TB, Scopinho AA, Biojone C, Correa FM, Resstel LB (2014) Involvement of dorsal hippocampus glutamatergic and nitrergic neurotransmission in autonomic responses evoked by acute restraint stress in rats. Neuroscience 258:364-373
66. Moreira FA, Wotjak CT (2010) Cannabinoids and anxiety. Curr Top Behav Neurosci 2:429-450
67. Moreira FA, Aguiar DC, Terzian AL, Guimaraes FS, Wotjak CT (2012) Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin? Neuroscience 204:186-192
68. Munhoz CD, Garcia-Bueno B, Madrigal JL, Lepsch LB, Scavone C, Leza JC (2008) Stress-induced neuroinflammation: mechanisms and new pharmacological targets. Braz J Med Biol Res 41:1037-1046
69. Murphy S, Simmons ML, Agullo L, Garcia A, Feinstein DL, Galea E, Reis DJ, Minc-Golomb D, Schwartz JP (1993) Synthesis of nitric oxide in CNS glial cells. Trends Neurosci 16:323-328
70. Musazzi L, Racagni G, Popoli M (2011) Stress, glucocorticoids and glutamate release: effects of antidepressant drugs. Neurochem Int 59:138-149
71. Niyuhire F, Varvel SA, Thorpe AJ, Stokes RJ, Wiley JL, Lichtman AH (2007) The disruptive effects of the CB1 receptor antagonist rimonabant on extinction learning in mice are task-specific. Psychopharmacology (Berl) 191:223-231
72. O'Dell TJ, Huang PL, Dawson TM, Dinerman JL, Snyder SH, Kandel ER, Fishman MC (1994) Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS. Science 265:542-546
73. Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Fernandez AP, Rodrigo J, Bosca L, Leza JC (2000) Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex. J Neurochemistry 74:785-791
74. Oosthuizen F, Wegener G, Harvey BH (2005) Nitric oxide as inflammatory mediator in post-traumatic stress disorder (PTSD): evidence from an animal model. Neuropsychiatr Disease Treatment 1:109-123
75. Pamplona FA, Prediger RD, Pandolfo P, Takahashi RN (2006) The cannabinoid receptor agonist WIN 55, 212-2 facilitates the extinction of contextual fear memory and spatial memory in rats. Psychopharmacology (Berl) 188:641-649
76. Patel S, Hillard CJ (2006) Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J Pharmacol Exp Ther 318:304-311
77. Pavesi E, Heldt SA, Fletcher ML (2013) Neuronal nitric-oxide synthase deficiency impairs the long-term memory of olfactory fear learning and increases odor generalization. Learn Mem 20:482-490
78. Peng YL, Liu YN, Liu L, Wang X, Jiang CL, Wang YX (2012) Inducible nitric oxide synthase is involved in the modulation of depressive behaviors induced by unpredictable chronic mild stress. J Neuroinflammation 9:75
79. Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nature reviews Neuroscience 4:873-884
80. Pissiota A, Frans O, Fernandez M, von Knorring L, Fischer H, Fredrikson M (2002) Neurofunctional correlates of posttraumatic stress disorder: a PET symptom provocation study. Eur Arch Psychiatry Clin Neurosci 252:68-75
81. Reich CG, Mohammadi MH, Alger BE (2008) Endocannabinoid modulation of fear responses: learning and state-dependent performance effects. J Psychopharmacol 22:769-777
82. Reif A, Schmitt A, Fritzen S, Chourbaji S, Bartsch C, Urani A, Wycislo M, Mossner R, Sommer C, Gass P, Lesch KP (2004) Differential effect of endothelial nitric oxide synthase (NOS-III) on the regulation of adult neurogenesis and behaviour. Eur J Neurosci 20:885-895
83. Resstel LB, Correa FM, Guimaraes FS (2008) The expression of contextual fear conditioning involves activation of an NMDA receptor-nitric oxide pathway in the medial prefrontal cortex. Cereb Cortex 18:2027-2035
84. Resstel LB, Moreira FA, Guimaraes FS (2009) Endocannabinoid system and fear conditioning. Vitam Horm 81:421-440
85. Rey AA, Purrio M, Viveros MP, Lutz B (2012) Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission. Neuropsychopharmacology 37:2624-2634
86. Riaza Bermudo-Soriano C, Perez-Rodriguez MM, Vaquero-Lorenzo C, Baca-Garcia E (2012) New perspectives in glutamate and anxiety. Pharmacol Biochem Behav 100:752-774
87. Rutkowska M, Jamontt J, Gliniak H (2006) Effects of cannabinoids on the anxiety-like response in mice. Pharmacol Rep 58:200-206
88. Shin LM, Orr SP, Carson MA, Rauch SL, Macklin ML, Lasko NB, Peters PM, Metzger LJ, Dougherty DD, Cannistraro PA, Alpert NM, Fischman AJ, Pitman RK (2004a) Regional cerebral blood flow in the amygdala and medial prefrontal cortex during traumatic imagery in male and female Vietnam veterans with PTSD. Arch Gen Psychiatry 61:168-176
89. Shin LM, Shin PS, Heckers S, Krangel TS, Macklin ML, Orr SP, Lasko N, Segal E, Makris N, Richert K, Levering J, Schacter DL, Alpert NM, Fischman AJ, Pitman RK, Rauch SL (2004b) Hippocampal function in posttraumatic stress disorder. Hippocampus 14:292-300
90. Smythies J (2013) Schizophrenia: one coat of many colors. Front Psychiatry 4:43
91. Spolidorio PC, Echeverry MB, Iyomasa M, Guimaraes FS, Del Bel EA (2007) Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus. Psychopharmacology (Berl) 195:183-192
92. Stellwagen D, Malenka RC (2006) Synaptic scaling mediated by glial TNF-Alpha. Nature 440:1054-1059
93. Suzuki A, Josselyn SA, Frankland PW, Masushige S, Silva AJ, Kida S (2004) Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci 24:4787-4795
94. Tonetto LL, Terzian AL, Del Bel EA, Guimaraes FS, Resstel LB (2009) Inhibition of the NMDA receptor/Nitric Oxide pathway in the dorsolateral periaqueductal gray causes anxiolyticlike effects in rats submitted to the Vogel conflict test. Behav Brain Funct 5:40
95. Varvel SA, Anum EA, Lichtman AH (2005) Disruption of CB(1) receptor signaling impairs extinction of spatial memory in mice. Psychopharmacology (Berl) 179:863-872
96. Vermetten E, Schmahl C, Southwick SM, Bremner JD (2007) Positron tomographic emission study of olfactory induced emotional recall in veterans with and without combatrelated posttraumatic stress disorder. Psychopharmacol Bull 40:8-30
97. Viveros MP, Marco EM, File SE (2005) Endocannabinoid system and stress and anxiety responses. Pharmacol Biochem Behav 81:331-342
98. Walton JC, Selvakumar B, Weil ZM, Snyder SH, Nelson RJ (2013) Neuronal nitric oxide synthase and NADPH oxidase interact to affect cognitive, affective, and social behaviors in mice. Behav Brain Res 256:320-327
99. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S, Liew FY (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411
100. Weitzdoerfer R, Hoeger H, Engidawork E, Engelmann M, Singewald N, Lubec G, Lubec B (2004) Neuronal nitric oxide synthase knock-out mice show impaired cognitive performance. Nitric oxide 10:130-140
101. Wilson RI, Yanovsky J, Godecke A, Stevens DR, Schrader J, Haas HL (1997) Endothelial nitric oxide synthase and LTP. Nature 386:338
102. Wilson RI, Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296:678-682
103. Wultsch T, Chourbaji S, Fritzen S, Kittel S, Grunblatt E, Gerlach M, Gutknecht L, Chizat F, Golfier G, Schmitt A, Gass P, Lesch KP, Reif A (2007) Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals. J Neural Transm Suppl 69-85